CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CNCE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/03/16	22:02	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/14	19:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/14	19:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/14	19:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/14	19:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:58	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:53	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:33	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:29	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:26	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01:23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/06	23:47	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/06	23:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/06	23:01	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/25	06:06	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/25	06:03	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/16	22:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/16	22:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/16	22:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/15	21:00	Business Wire	Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/15	07:07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/15	04:36	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/13	23:26	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CNCE	Concert Pharmaceuticals Inc